Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck Ends Development of Two Experimental Cancer Drugs
10:05am, Tuesday, 17'th Dec 2024
MRK's decision to discontinue the development of two cancer drugs follows a series of setbacks in multiple late-stage studies.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--FDA Accepts BLA for Clesrovimab, Merck's Investigational Long-Acting MAb Designed to Protect Infants from RSV During their First RSV Season.
Merck: Buy Opportunity Backed By Growth
05:24am, Tuesday, 17'th Dec 2024
Merck: Buy Opportunity Backed By Growth
Merck discontinues development of 2 cancer drugs after trial failures
04:38pm, Monday, 16'th Dec 2024
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the discontinuation of the clinical development programs for vibos
CHMP Endorses Merck's Kidney Cancer Drug for Two Indications
12:01pm, Monday, 16'th Dec 2024
The CHMP's opinion is based on positive results from two late-stage studies on MRK's Welireg in two indications associated with renal cell carcinoma.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the Nati
Merck Has Become Very Cheap Again
12:35am, Monday, 16'th Dec 2024
Merck's shares have declined, making its dividend yield climb and valuation compress, presenting an attractive investment opportunity at current prices. Keytruda, the company's largest drug, continues
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--WELIREG CHMP Opinion for VHL & RCC.
Merck (MRK) Ascends While Market Falls: Some Facts to Note
06:51pm, Thursday, 12'th Dec 2024
Merck (MRK) reachead $101.25 at the closing of the latest trading day, reflecting a +1.5% change compared to its last close.
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
02:23pm, Thursday, 12'th Dec 2024
It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others.
14 Upcoming Dividend Increases
11:35am, Thursday, 12'th Dec 2024
I focus on companies consistently increasing dividends and beating benchmarks, using data from the U.S. Dividend Champions spreadsheet and NASDAQ. The list includes companies with at least five years
2 Ideal Buys From 50 'Safer' Dividends In 100 December Sustainables
07:35am, Thursday, 12'th Dec 2024
Calvert Research and Management ranked the 1,000 largest publicly traded companies by ESG performance, identifying the top 100 sustainable companies for 2024. Among 78 dividend paying sustainable comp
Merck (MRK) Stock Sinks As Market Gains: Here's Why
06:55pm, Wednesday, 11'th Dec 2024
Merck (MRK) closed at $99.75 in the latest trading session, marking a -1.24% move from the prior day.
LYNPARZA® (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial
10:22am, Wednesday, 11'th Dec 2024
RAHWAY, N.J.--(BUSINESS WIRE)--AstraZeneca and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term results from the OlympiA Phase 3 trial which showed LY
